文献速递消化道肿瘤与早癌消化内镜

单细胞组学与靶向治疗时代结直肠癌干细胞的临床意义

Clinical Implications of Colorectal Cancer Stem Cells in the Age of Single-Cell Omics and Targeted Therapies.
PubMed 文献 · Gastroenterology · 2021-02-19

本文综述结直肠癌干细胞(CSC)概念的提出与验证,指出CSC可导致传统、靶向及免疫治疗耐药并驱动肿瘤进展。CSC表面标志物已可用于识别与分离,单细胞组学(全基因组测序、RNA测序、表观遗传分析)为发现可靶向分子通路及开发根除CRC的新策略提供机会,并讨论其对已批准和实验性靶向治疗的意义。

要点

  • CSC是肿瘤内具有更强克隆性与成瘤能力的细胞亚群,可驱动治疗耐药与进展。
  • CRC CSC的表面标志物已建立,可用于识别与前瞻性分离。
  • 单细胞组学为发现CSC可靶向通路及开发根除CRC策略提供新机会。

核心结论

  • CSC可导致结直肠癌对传统、靶向及免疫治疗耐药,并通过CSC内在分子机制驱动进展。
  • 单细胞组学应用于CSC表征有望发现新的可靶向分子通路并开发根除CRC的新策略。

研究设计与样本

  • 综述类文章,围绕CSC概念、CRC CSC的验证证据及单细胞组学与靶向治疗的最新进展进行汇总讨论。

主要发现

  • CRC中CSC的存在最初通过人至小鼠异种移植实验中该细胞亚群增强的克隆性与成瘤能力得到证明,随后在小鼠谱系追踪研究中被确认。
  • CRC CSC的表面标志物及其前瞻性分离方法现已建立。
  • 单细胞组学技术包括全基因组测序、RNA测序和表观遗传分析,可用于CSC表征。

临床怎么用

  • 可利用已建立的CRC CSC表面标志物识别和分离CSC,用于研究与治疗开发。
  • 将单细胞组学(全基因组测序、RNA测序、表观遗传分析)用于CSC表征,以发现可靶向分子通路。
  • 关注CSC对传统、靶向及免疫治疗耐药的影响,并探索针对CSC的根除策略。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

The cancer stem cell (CSC) concept emerged from the recognition of inherent tumor heterogeneity and suggests that within a given tumor, in analogy to normal tissues, there exists a cellular hierarchy composed of a minority of more primitive cells with enhanced longevity (ie, CSCs) that give rise to shorter-lived, more differentiated cells (ie, cancer bulk populations), which on their own are not capable of tumor perpetuation. CSCs can be responsible for cancer therapeutic resistance to conventional, targeted, and immunotherapeutic treatment modalities, and for cancer progression through CSC-intrinsic molecular mechanisms. The existence of CSCs in colorectal cancer (CRC) was first established through demonstration of enhanced clonogenicity and tumor-forming capacity of this cell subset in human-to-mouse tumor xenotransplantation experiments and subsequently confirmed through lineage-tracing studies in mice. Surface markers for CRC CSC identification and their prospective isolation are now established. Therefore, the application of single-cell omics technologies to CSC characterization, including whole-genome sequencing, RNA sequencing, and epigenetic analyses, opens unprecedented opportunities to discover novel targetable molecular pathways and hence to develop novel strategies for CRC eradication. We review recent advances in this field and discuss the potential implications of next-generation CSC analyses for currently approved and experimental targeted CRC therapies.

来源:Gastroenterology,查看原文。版权归原作者所有。

引用

  1. Frank MH, Wilson BJ, Gold JS, et al. Clinical Implications of Colorectal Cancer Stem Cells in the Age of Single-Cell Omics and Targeted Therapies. Gastroenterology. 2021. PMID: 33617889. doi:10.1053/j.gastro.2020.12.080

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。